Sampling Time points in Bioequivalence studies [Design Issues]

posted by taresh41  – Mumbai, 2009-07-20 11:27 (6179 d 23:33 ago) – Posting: # 3970
Views: 12,934

Dear All,
I have a query regarding sampling time points selection in Bioequivalence studies.

e.g.: In case of a drug having tmax = 1.50 to 3.00 hours and Half life around 12 hours, considering the tmax and half life from literature and all other pharmacokinetic parameters the total no. of time points are 22 (sampling up to 48.00 hours).

My query is,
  1. If i design a BE study with large no. of sampling time points will it affect Cmax, tmax and AUC?
  2. Can i decrease the time points after tmax?
  3. If i decrease time points after tmax how will it affect the Cmax and AUC?
  4. What is the effect of adding large no. of close time points at tmax and what is the effect of adding less no. of time points at the tmax, how both the cases will affect the Cmax, tmax and AUC?

Thanks & Regards,
Taresh

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
127 visitors (0 registered, 127 guests [including 14 identified bots]).
Forum time: 11:00 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5